Pharma's Almanac

𝐏𝐢𝐨𝐧𝐞𝐞𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐃𝐍𝐀 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 By tackling high costs, production challenges, and environmental impact, Touchlight’s enzymatic dbDNA technology is driving a more sustainable, scalable, and cost-effective alternative to traditional plasmid DNA production. 🔗 𝘓𝘦𝘢𝘳𝘯 𝘮𝘰𝘳𝘦 𝘩𝘦𝘳𝘦: https://lnkd.in/eUJGFVBq #BiopharmaInnovation #AdvancedTherapies #SyntheticDNA #Sustainability #GeneTherapy Lisa Caproni, PhD, Jill Makin, Tom Adie, PhD, Elena Stoyanova, PhD

If you haven't heard already, CorePharma®will be attending DCAT in March! We look forward to seeing you. Please reach out to CDMO@corepharma.com to schedule. #DCAT #CDMO #OSD #SmallMolecule #Development #Manufacturing

𝐎𝐩𝐭𝐢𝐦𝐢𝐳𝐢𝐧𝐠 𝐏𝐡𝐚𝐫𝐦𝐚 𝐋𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐰𝐢𝐭𝐡 𝐅𝐫𝐨𝐧𝐭𝐢𝐞𝐫 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 From multiple hand-offs to tarmac delays, pharma supply chains face constant challenges. But with cutting-edge logistics strategies, companies like Frontier Scientific Solutions are ensuring product integrity, minimizing losses, and streamlining global distribution. Learn more here: https://lnkd.in/e2FPkEZK #PharmaLogistics #SupplyChain #Biopharma #Logistics #Biomanufacturing Michael Braddock II, Tony Yeates

🌱 𝐓𝐚𝐜𝐤𝐥𝐢𝐧𝐠 𝐏𝐥𝐚𝐬𝐭𝐢𝐜 𝐖𝐚𝐬𝐭𝐞 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚: 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬 & 𝐂𝐡𝐚𝐥𝐥𝐞𝐧𝐠𝐞𝐬 𝐀𝐡𝐞𝐚𝐝 The pharma industry is making strides toward sustainability, but plastic waste remains a major challenge. Sophie Lutter from Pharma's Almanac explores the progress made so far and the hurdles that must be addressed as the industry works toward greener solutions. 🔗 𝘙𝘦𝘢𝘥 𝘮𝘰𝘳𝘦: https://lnkd.in/e36F4mgV #Sustainability #Pharma #SustainableManufacturing #PharmaSustainability #GreenPharma Nigel Walker, Joel Eichmann, Caitlin Harclerode, Helen Liang, David Alvaro

𝐇𝐨𝐰 𝐆𝐋𝐏-1 𝐃𝐞𝐦𝐚𝐧𝐝 𝐢𝐬 𝐑𝐞𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐂𝐨𝐥𝐝 𝐂𝐡𝐚𝐢𝐧 𝐋𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 With the rising demand for GLP-1 drugs for type 2 diabetes and obesity, the pressure is mounting on temperature-controlled storage and global logistics capacity. Explore how companies like Frontier Scientific Solutions are adapting to this growing demand: https://lnkd.in/e8m57GkQ #GLP1 #PharmaSupplyChain #Biopharma #Logistics #FrontierScientificSolutions Tony Yeates, Michael Braddock II

The Dry Powder Inhaler Market is on the rise! According to Future Market Insights, Inc. and Yahoo Finance, the Dry Powder Inhaler (DPI) Market is poised for significant growth, with a market value of USD 20.83 billion in 2024, projected to climb to USD 29.95 billion by 2034, representing a steady CAGR of 3.70% over the forecast period. Learn how Experic works closely with you to provide truly customized solutions to meet your DPI development and manufacturing needs: https://lnkd.in/d8TaETV #DrugDevelopment #CDMO #Innovation #PharmaManufacturing #DPI

𝐄𝐧𝐬𝐮𝐫𝐢𝐧𝐠 𝐏𝐮𝐫𝐢𝐭𝐲: 𝐍𝐮𝐜𝐥𝐞𝐚𝐬𝐞-𝐅𝐫𝐞𝐞 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 Discover the strategies that enhance product safety and streamline bioprocessing. In this article, Richard Fry from SaniSure dives into how innovative manufacturing processes, rigorous testing protocols, and Quality by Design (QbD) are shaping nuclease-free, GMP-compliant solutions to protect sensitive biologics. Learn more here: https://lnkd.in/emVfY2k6 #Biopharma #GMPCompliance #QualityByDesign #Bioprocessing #SaniSure Dr. Alex Van Hagen Nick Brust Rina Ebert Jeff Chase

Frontier Scientific Solutions’ state-of-the-art cGMP facility is set to revolutionize the life sciences supply chain, offering unprecedented speed, security, and efficiency for temperature-sensitive pharmaceutical and biopharmaceutical products. With its strategic location and Free Trade Zone (FTZ) designation, the Wilmington International Airport (ILM) facility will serve as a direct global gateway connecting North America and Europe, ensuring life-saving treatments reach patients faster than ever. + Largest GMP temperature-controlled facility in North America + Enhancing global connectivity for life sciences supply chains + Streamlined customs processing with Free Trade Zone benefits + Strengthening Wilmington’s position as a global life sciences hub Read more in the full release: https://lnkd.in/eJEVNhTp Leandro Moreira | Jeffrey Bourk, A.A.E., MBA #pharma #pharmaindustry #lifescience #logistics #pressrelease

Samsung Biologics is at the forefront of the CDMO industry with its digital strategy which increases client data interface and enhanced performance.

Our Vice President of Environment, Health and Safety, Brian Peutherer recently participated in Pharma's Almanac's roundtable on minimising environmental impact within pharmaceutical manufacturing. Click below to find out more. #CDMO #PDMO #DrugManufacture #Sustainability #WeAreSterling